Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiFrancesco

Showing results (531-540 of 544) with videos related to

Pageof 55
Sort By:
Brain : a Journal of Neurology|October 24, 2018
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyondCarla Marini, Alessandro Porro, Agnès Rastetter, et al.
Neurology|June 8, 2021
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body DisordersAndrea Pilotto, Alberto Romagnolo, Andrea Scalvini, et al.
Heart Rhythm|December 5, 2020
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rateAlicia D'Souza, Yanwen Wang, Cali Anderson, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comprehensive classification of HCN1 variants linked to neurodevelopmental disorders with and without epilepsyRoberta Castelli, Carla Marini, Alessandro Porro, et al.
Psychological Medicine|May 15, 2023
The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severityS Siddi, R Bailon, I Giné-Vázquez, et al.
Neurology|September 17, 2021
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort StudyLaura Antolini, Jacopo C DiFrancesco, Marialuisa Zedde, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
Epilepsia Open|February 27, 2025
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)Giorgia Giussani, Elisa Bianchi, Edoardo Carlando, et al.
BMC Psychiatry|February 22, 2022
Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement studyFaith Matcham, Daniel Leightley, Sara Siddi, et al.
Pageof 55

Showing results (531-540 of 544) with videos related to

Sort By:
Pageof 55
Brain : a Journal of Neurology|October 24, 2018
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyondCarla Marini, Alessandro Porro, Agnès Rastetter, et al.
Neurology|June 8, 2021
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body DisordersAndrea Pilotto, Alberto Romagnolo, Andrea Scalvini, et al.
Heart Rhythm|December 5, 2020
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rateAlicia D'Souza, Yanwen Wang, Cali Anderson, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Comprehensive classification of HCN1 variants linked to neurodevelopmental disorders with and without epilepsyRoberta Castelli, Carla Marini, Alessandro Porro, et al.
Psychological Medicine|May 15, 2023
The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severityS Siddi, R Bailon, I Giné-Vázquez, et al.
Neurology|September 17, 2021
Spontaneous ARIA-like Events in Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Prospective Longitudinal Cohort StudyLaura Antolini, Jacopo C DiFrancesco, Marialuisa Zedde, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
Epilepsia Open|February 27, 2025
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW)Giorgia Giussani, Elisa Bianchi, Edoardo Carlando, et al.
BMC Psychiatry|February 22, 2022
Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement studyFaith Matcham, Daniel Leightley, Sara Siddi, et al.
Pageof 55